Bio-Techne
TECH
Bio-Techne (TECH) earnings history
Most recent quarter
- Fiscal period
- Q3 2026
- Period end
- Mar 31, 2026
- EPS actual
- $0.53
- EPS estimate
- $0.53
- EPS surprise
- −0.79%
- Revenue surprise
- −1.48%
- Revenue
- $311.4M
- Revenue estimate
- $316.1M
- Reported
- May 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | May 6, 2026 | $0.53 | $0.53 | −0.79% | $311.4M | SEC |
| Q2 2026 | Feb 4, 2026 | $0.43 | $0.46 | +5.99% | $295.9M | SEC |
| Q1 2026 | Nov 5, 2025 | $0.42 | $0.42 | −0.33% | $286.6M | SEC |
| Q4 2025 | Aug 6, 2025 | $0.50 | $0.53 | +6.13% | $317.0M | SEC |
| Q3 2025 | May 7, 2025 | $0.51 | $0.56 | +10.32% | $316.2M | SEC |
| Q2 2025 | Feb 5, 2025 | $0.39 | $0.42 | +8.75% | $297.0M | SEC |
| Q1 2025 | Oct 30, 2024 | $0.38 | $0.42 | +10.06% | $289.5M | SEC |
| Q4 2024 | Aug 7, 2024 | $0.49 | $0.49 | −0.99% | $306.1M | SEC |
| Q3 2024 | May 1, 2024 | $0.45 | $0.48 | +6.01% | $303.4M | SEC |
| Q2 2024 | Feb 1, 2024 | $0.41 | $0.40 | −2.96% | $272.6M | SEC |
| Q1 2024 | Oct 31, 2023 | $0.43 | $0.41 | −5.68% | $276.9M | SEC |
| Q4 2023 | Aug 8, 2023 | $0.55 | $0.55 | +0.64% | $301.3M | SEC |
| Q3 2023 | May 3, 2023 | $0.53 | $0.53 | +0.38% | $294.1M | SEC |
| Q2 2023 | Feb 2, 2023 | $0.49 | $0.47 | −3.71% | $271.6M | SEC |
| Q1 2023 | Nov 1, 2022 | $0.46 | $0.45 | −2.75% | $269.7M | SEC |
| Q4 2022 | Aug 4, 2022 | $0.52 | $0.51 | −1.27% | $288.2M | SEC |
| Q3 2022 | May 4, 2022 | $0.50 | $0.54 | +7.15% | $290.4M | SEC |
| Q2 2022 | Feb 1, 2022 | $0.45 | $0.47 | +5.05% | $269.3M | — |
| Q1 2022 | Nov 2, 2021 | $0.43 | $0.46 | +6.27% | $257.7M | — |
| Q4 2021 | Aug 5, 2021 | $0.43 | $0.47 | +9.92% | $259.0M | — |
Quarterly revenue
Frequently asked questions
When did Bio-Techne (TECH) last report earnings?
Bio-Techne last reported on May 6, 2026, covering fiscal Q3 2026.
Did TECH beat earnings estimates?
No. Bio-Techne reported EPS of $0.53 for Q3 2026 against a $0.53 estimate — a 0.79% miss.
How much revenue did TECH report last quarter?
Bio-Techne reported $311.4M in revenue for Q3 2026, against a consensus estimate of $316.1M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.